Latest news
Should Gilead’s Swing to a Full‑Year Loss Outlook Require Action From Gilead Sciences (GILD) Investors? - simplywall.stsimplywall.st · Sat, 08 Aug 2026 08:25:24 GMTDow Jones Top Company Headlines at 9 PM ET: White House AI Guidelines Exempt U.S. Open Models From Government Review | The ... - BitgetBitget · Wed, 05 Aug 2026 13:33:27 GMTGilead Raised HIV Guidance on Its Q2 Earnings Call. Here’s What That Means for GILD Stock. - TIKR.comTIKR.com · Wed, 05 Aug 2026 10:39:48 GMTDow Jones Top Company Headlines at 1 AM ET: SpaceX Says Spending Spree Is Supercharging AI Revenues | The ... - BitgetBitget · Wed, 05 Aug 2026 05:31:28 GMTGilead Sciences (GILD) Reports Q2 Loss, Beats Revenue Estimates - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 21:15:02 GMTGilead Sciences (NASDAQ:GILD) Beats Expectations in Strong Q2 CY2026 - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 21:05:19 GMTGilead Sciences Swings to Loss on R&D Costs as HIV-Drug Sales Lift Revenue - WSJWSJ · Tue, 04 Aug 2026 20:31:00 GMTGilead Sciences Q2 Swings To Adjusted Loss, Revenue Rises - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 20:09:58 GMT